Skip to main content
. Author manuscript; available in PMC: 2010 Jun 9.
Published in final edited form as: Cancer Prev Res (Phila). 2008 Nov;1(6):413–423. doi: 10.1158/1940-6207.CAPR-08-0121

Figure 1.

Figure 1

Percent of probes across the genome with copy gain, loss and LOH in different stages of neoplastic progression measured in the 33K SNP array. * % SNP probes with LOH was calculated using only those SNPs that were heterozygous in the paired constitutive control.